Treatment with c-Myc or PI3K/Akt pathway inhibitors induced Bim upregulation and apoptosis, indicating that Bim is repressed downstream of c-Myc and PI3K/Akt in high-risk T-ALL [506]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.